The Fanconi Syndrome

作者: Orson W. Moe , Donald W. Seldin , Michel Baum

DOI: 10.1016/B978-0-12-449851-8.00010-3

关键词: Fumarylacetoacetate hydrolaseKidneyChemistryCystinosisReabsorptionInternal medicineTyrosineFanconi syndromeEndocrinologyCystinosinTyrosinemia

摘要: Publisher Summary This chapter focuses on a group of congenital and acquired disorders that are not due to single solute transporter defect but rather appear result from more generalized heterogeneous dysfunctions the entire proximal tubule. The complete or classical Fanconi syndrome may be defined as an impairment tubule reabsorption sodium, bicarbonate, potassium, phosphate, glucose, amino acids, uric acid low-molecular-weight proteins, peptides, well other organic solutes. Cystinosis is most common cause in childhood serves prototype this syndrome. lysosomal storage disorder where defective cystine transporter, cystinosin, fails extrude lysosomes. Fumarylacetoacetate hydrolase (FAH) liver kidney last enzyme tyrosine catabolic pathway. Patients with mutations FAH have tyrosinemia develop after ingestion phenylalanine. One accumulated metabolites, succinylacetone, nephrotoxic sole agent. Over short term, reversible upon removal phenylalanine diet. Heavy metals (cadmium, mercury, lead, chromium, platinum) transported by also toxic same epithelia. prime target heavy metal toxicity because its ability accumulate metals. In humans, chronic exposure can range renal failure. Cadmium-induced usually only occurs years industrial exposure, while lead-induced occur large acute prolonged low levels exposure.

参考文章(268)
K F LaNoue, A C Schoolwerth, Metabolite transport in mitochondria. Annual Review of Biochemistry. ,vol. 48, pp. 871- 922 ,(1979) , 10.1146/ANNUREV.BI.48.070179.004255
Erik I. Christensen, Jakub Gburek, Protein reabsorption in renal proximal tubule-function and dysfunction in kidney pathophysiology. Pediatric Nephrology. ,vol. 19, pp. 714- 721 ,(2004) , 10.1007/S00467-004-1494-0
Chih-Sheng Tsai, Yi-Chou Chen, Han-Hsiang Chen, Chih-Jen Cheng, Shih-Hua Lin, An Unusual Cause of Hypokalemic Paralysis: Aristolochic Acid Nephropathy with Fanconi Syndrome The American Journal of the Medical Sciences. ,vol. 330, pp. 153- 155 ,(2005) , 10.1097/00000441-200509000-00012
R. Garty, M. Cooper, E. Tahachnik, The fanconi syndrome associated with hepatic glycogenosis and abnormal metabolism of galactose The Journal of Pediatrics. ,vol. 85, pp. 821- 823 ,(1974) , 10.1016/S0022-3476(74)80351-3
LOUIS J. ELSAS, Wilson's Disease with Reversible Renal Tubular Dysfunction Annals of Internal Medicine. ,vol. 75, pp. 427- 433 ,(1971) , 10.7326/0003-4819-75-3-427
SANGHO LEE, TAEWON LEE, BYUNGCHEOL LEE, HYUCKJAI CHOI, MUNHO YANG, CHUN-GYOO IHM, MYUNGJAE KIM, Fanconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid. Nephrology. ,vol. 9, pp. 126- 129 ,(2004) , 10.1111/J.1440-1797.2003.00232.X
M Pontoglio, S Sreenan, M Roe, W Pugh, D Ostrega, A Doyen, A J Pick, A Baldwin, G Velho, P Froguel, M Levisetti, S Bonner-Weir, G I Bell, M Yaniv, K S Polonsky, Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. Journal of Clinical Investigation. ,vol. 101, pp. 2215- 2222 ,(1998) , 10.1172/JCI2548
F. De Lorenzo, J. Hargreaves, V. V. Kakkar, Phosphate diabetes in patients with chronic fatigue syndrome. Postgraduate Medical Journal. ,vol. 74, pp. 229- 232 ,(1998) , 10.1136/PGMJ.74.870.229
Nancy D. Leslie, Insights into the pathogenesis of galactosemia. Annual Review of Nutrition. ,vol. 23, pp. 59- 80 ,(2003) , 10.1146/ANNUREV.NUTR.23.011702.073135
James E. Springate, Judith B. van Liew, Nephrotoxicity of ifosfamide in rats Journal of Applied Toxicology. ,vol. 15, pp. 399- 402 ,(1995) , 10.1002/JAT.2550150510